COVID-19: WHO launches “ACT Accelerator”

Amaka E. Nliam

0
63
Dr. Tedros Adhanom Ghebreyesus, WHO Director-General.

The World Health Organization (WHO) has said that to bring #COVID19 under control, and to save lives, there is need for effective vaccines, diagnostics, and therapeutics – in unprecedented quantities and at unprecedented speed, hence the launch of the “Access to #COVID19 Tools Accelerator” (ACT Accelerator).

The WHO Director-General, Dr. Tedros Adhanom Ghebreyesus, said this while giving further details on how the ACT Accelerator is working.

Launched two months ago, the ACT Accelerator is a new, ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 diagnostics, therapeutics, and vaccines.

It brings together governments, health organizations, scientists, businesses, civil societies, philanthropists, who have joined forces to speed up an end to the pandemic.

The Access to #COVID19 Tools Accelerator’s health system connector aims to build countries’ capacity to deploy the new tools effectively when they are ready.

 

The global initiative is led by the work of partner organizations collaborating under 4 pillars: diagnostics, therapeutics, vaccines, and strengthening health systems.

The Access to #COVID19 Tools Accelerator’s diagnostics pillar co-led by @FINDdx and @GlobalFund aims to save 9 million lives and avoid 1.6 billion further infections through the power of equitable access to simple, accurate and affordable tests.

The Access to #COVID19 Tools Accelerator’s therapeutics pillar targets development, manufacture, procurement and equitable distribution 245 million courses of treatment for populations in low-and-middle income countries within 12 months.

Led by @UNITAID and @wellcometrus (on behalf of the ACT Accelerator), it seeks to accelerate the development and equitable delivery of treatments at all stages of the disease, ensuring they are accessible to all.

The Access to #COVID19 Tools Accelerator’s vaccine pillar combines @CEPIvaccines’s leadership in vaccine development and investment in manufacturing with @gavi’s track record in revolutionizing access and delivery and WHO’s oversight of regulation, policy and allocation.
It aims to ensure that vaccines are developed as rapidly as possible, manufactured at the right volumes without compromising on safety and delivered to those that need them most.

 

The Access to #COVID19 Tools Accelerator (ACT-Accelerator) will end the pandemic faster by ensuring that the tools developed are allocated rationally and equitably around the world, maximizing the chances of global success of finally ending the pandemic.

It is, therefore, calling for USD31.3 billion over the next 12 months in its new consolidated investment case.

 

Amaka E. Nliam

 

 

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.